From: <[log in to unmask]>
I am only aware of the following two articles related to this rare disease.
Hopefully others can be of more help.
1
UI - 94104107
AU - Ohno M
AU - Goto I
TI - [Hallervorden-Spatz disease]
RF - REVIEW ARTICLE: 18 REFS.
AD - Department of Neurology, Faculty of Medicine, Kyushu University.
MH - English Abstract
MH - Genes, Recessive
MH - Globus Pallidus/PATHOLOGY
MH - *Hallervorden-Spatz Syndrome/GENETICS/PATHOLOGY
MH - Human
MH - Prognosis
MH - Substantia Nigra/PATHOLOGY
PT - JOURNAL ARTICLE
PT - REVIEW
PT - REVIEW, TUTORIAL
LA - Jpn
SO - Nippon Rinsho 1993 Nov;51(11):2957-61
2
UI - 93176018
AU - Seibel MO
AU - Date ES
AU - Zeiner H
AU - Schwartz M
TI - Rehabilitation of patients with Hallervorden-Spatz syndrome.
AD - Department of Functional Restoration, Stanford University Medical
Center, CA.
MH - Activities of Daily Living
MH - Adult
MH - Carbidopa/ADMINISTRATION & DOSAGE
MH - Case Report
MH - Drug Therapy, Combination
MH - Exercise Therapy/METHODS
MH - Hallervorden-Spatz Syndrome/DRUG THERAPY/PHYSIOPATHOLOGY/
*REHABILITATION
MH - Human
MH - Levodopa/ADMINISTRATION & DOSAGE
MH - Male
MH - Movement Disorders/PHYSIOPATHOLOGY/REHABILITATION
MH - Patient Care Team
PT - JOURNAL ARTICLE
LA - Eng
SO - Arch Phys Med Rehabil 1993 Mar;74(3):328-9
